SecBot SecBot
8-K ·Filed Mar 11, 2026

BIIB

BIOGEN INC.
NEUTRAL
Impact 3/10
Horizondays Processed8mo ago SEC0000950157-26-000280
8-K context-dependent: Items 5.02
Actionable Insight • Neutral

Monitor for supplemental disclosures or press releases from Biogen regarding leadership changes. Absent details, this event should not drive trading decisions.

DirectionNeutral
Confidencelow
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$184.10
T+0 close · Mar 11, 2026 · via day close
Latest settled
+6.11%
T+60 · $195.34
Vs SPY
−4.59%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Mar 12 $184.10entry
  2. T+1 · 8mo ago −1.69%α −1.10% · $180.98
  3. T+5 · 8mo ago −0.66%α +0.32% · $182.88
  4. T+20 · 7mo ago −6.11%α −8.08% · $172.86
  5. T+60 · 5mo ago +6.11%α −4.59% · $195.34
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Analysis based on filing metadata only, document content was unavailable. The filing is an 8-K with Item 5.02 disclosed, indicating a departure or appointment of directors or officers at Biogen Inc. (BIIB), but no details are available to assess the nature, participants, or implications of the change.

Key Facts

  • Filing type is 8-K, indicating a material event.
  • Item 5.02 reported: Departure or appointment of directors or officers.
  • No document content available to determine who was involved, whether it was a resignation, retirement, or termination, or if a replacement was named.

Financial Impact

Not specified

Risk Factors

  • Potential for unexpected executive turnover if the departure was involuntary or involved C-suite executives.
  • Lack of transparency due to unavailable filing content limits ability to assess governance stability.

Market Snapshot

Exchange
Nasdaq
Analyst Consensus
47% bullish (43 analysts)

Investment Themes

Documents Analyzed

Report based on filing metadata.

Track record

34 reports on BIIB

Performance horizon

10 of 12 bullish or bearish reports moved the stock their way by T+60. Best: +15.73% at T+60 after the Jul 13, 2026 report. 16 of 17 went positive at some point.

Filters
  1. Nov 12, 20264d ago Press Release Neutral 3/10 Entry $253.40 Now $251.65 −0.69% settles Feb 11
  2. Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $253.25 Now $251.65 −0.63% settles Feb 8
  3. Nov 9, 20267d ago Press Release Neutral 4/10 Entry $254.87 Now $251.65 −1.26% settles Feb 5
  4. Oct 28, 202619d ago Institutional Cluster Neutral 2/10 Entry $244.05 Now $251.65 +3.11% settles Jan 26
  5. Oct 28, 202619d ago 8-K Bullish 6/10 Entry $244.05 Now $251.65 +3.11% settles Jan 26
  6. Oct 19, 202628d ago Press Release Neutral 4/10 Entry $233.48 Now $251.65 +7.78% settles Jan 14
  7. Oct 12, 20265w ago ANALYST-UPGRADE Bullish 6/10 Entry $229.41 Now $251.65 +9.69% settles Jan 7
  8. Oct 2, 20266w ago Press Release Bullish 6/10 Entry $219.88 Now $251.65 +14.45% settles Dec 29
  9. Sep 17, 20268w ago Press Release Bullish 5/10 Entry $215.50 Now $251.65 +16.77% settles Dec 14
  10. Sep 3, 202610w ago Press Release Neutral 4/10 Entry $220.83 Now $251.65 +13.96% settles Dec 1
Showing 10 of 34

US Market Status

Market Closed · Opens Wed (11h 30m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 11, 2026